Kitov Pharmaceuticals to Present at Pioneers 2016, Presented by Joseph Gunnar, in NYC on

Pharmaceuticals to Present at Pioneers 2016, Presented by Joseph Gunnar, in NYC on May 5, 2016

AVIV, Israel, May 4, 2016 /(GLOBE NEWSWIRE)/ -- Kitov

Pharmaceuticals (NASDAQ/TASE: KTOV), a late-stage drug development company, today announced that Dr. J. Paul Waymack,

Kitov's Chairman of the Board and Chief Medical Officer will present at the upcoming

PIONEERS 2016 conference, presented by Joseph Gunnar & Co. LLC, taking place on May 5, 2016 in New York.

PIONEERS 2016, presented

Date: Thursday, May 5, 2016

Location: New York Palace Hotel, Hubbard 1, New York City

About Kitov Pharmaceuticals

Pharmaceuticals Holdings Ltd. is a pharmaceutical company focused on the development of therapeutic candidates for the simultaneous

treatment of various clinical conditions. In particular, Kitov focuses on developing combinations of existing drugs in advanced

stages of development. Kitov's lead drug, KIT-302, is formulated for the simultaneous treatment of two clinical conditions -

pain caused by osteoarthritis (OA) and hypertension (high blood pressure), which can be pre-existing or caused by the treatment

for OA. KIT-302 is based on celecoxib, the active ingredient of a known and approved-for-use drug designed primarily to relieve

pain caused by OA, and the generic drug amlodipine besylate. Kitov is traded on the Nasdaq Capital Market (KTOV) and the Tel-Aviv

Stock Exchange (KTOV).

more information, the content of which is not part of this press release, please visit http://kitovpharma.com/

Forward-Looking Statements

press release contains forward-looking statements about the Company's expectations, beliefs and intentions. Forward-looking statements

can be identified by the use of forward-looking words such as "believe", "expect", "intend", "plan",

"may", "should", "could", "might", "seek", "target", "will",

"project", "forecast", "continue" or "anticipate" or their negatives or variations of these

words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking

statements involve certain risks and uncertainties, including, among others, risks impacting the ability of the Company to complete

any public offering of its securities because of general market conditions or other factors and risks that could cause the Company's

results to differ materially from those expected by Company management. Any forward-looking statement in this press release speaks

only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking

statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable

securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading

"Risk Factors" in Kitov Pharmaceuticals Holdings Ltd.'s Registration Statement on Form F-1 filed with the SEC, which

is available on the SEC's website, www.sec.gov.

LifeSci Advisors, LLC